{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1279"},{"groupId":"OG001","value":"1064"}]}],"title":"0-1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"307"},{"groupId":"OG001","value":"247"}]}],"title":"2-3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"60"}]}],"title":"4-5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"19"}]}],"title":">5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"71"},{"groupId":"OG001","value":"50"}]}],"title":"Missing"}],"denoms":[{"counts":[{"groupId":"OG000","value":"1761"},{"groupId":"OG001","value":"1440"}],"units":"Participants"}],"description":"Charlson Comorbidity Index (CCI) was used to represent number of participants with co-morbidities. CCI is a method of categorizing comorbidities of participants. Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a participant. A score of 0 = no comorbidities found, 1 = not ill, 2 = mildly ill, 3 = moderately ill, 4 = severely ill, and ≥5 = moribund. The higher the score, the more likely the predicted outcome resulted in mortality or higher resource use.","groups":[{"description":"Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).","id":"OG000","title":"NDMM"},{"description":"Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).","id":"OG001","title":"RRMM"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All Enrolled Population included all participants who signed the inform consent form. Overall number of participants analyzed is the number of participants available for analysis.","reportingStatus":"POSTED","timeFrame":"Baseline up to 5 years","title":"Number of Participants With Co-morbidities","type":"PRIMARY","unitOfMeasure":"Participants"}